RSS-Feed abonnieren
DOI: 10.1055/s-0031-1293207
Testing for Inherited Thrombophilia in Recurrent Miscarriage
Publikationsverlauf
Publikationsdatum:
08. Dezember 2011 (online)

ABSTRACT
Approximately 1–5% of women trying to conceive experience recurrent miscarriage, and in 50% of these women, the cause of the preceding miscarriages is unknown. Inherited thrombophilias such as factor V Leiden mutation, prothrombin gene mutation (PT 20210A), and deficiencies of natural anticoagulants protein C, protein S, and antithrombin are associated with recurrent miscarriage. Knowledge of the association between inherited thrombophilia and recurrent miscarriage and of potential treatment options for improving chances of a live birth could tempt physicians to test for inherited thrombophilia in women with recurrent miscarriage. However, the strength of the association between inherited thrombophilia and recurrent miscarriage is not very strong, and more importantly, no evidence indicates that the use of anticoagulants improves the chance of live birth in these women. With the current state of evidence, testing for inherited thrombophilia should not lead to altered clinical management and therefore, should not be performed routinely in women with recurrent miscarriage but only in the context of scientific studies.
KEYWORDS
Pregnancy - inherited thrombophilia - adverse pregnancy outcome - recurrent miscarriage
REFERENCES
- 1
Farquharson R G, Jauniaux E, Exalto N. ESHRE Special Interest Group for Early Pregnancy (SIGEP) .
Updated and revised nomenclature for description of early pregnancy events.
Hum Reprod.
2005;
20
(11)
3008-3011
MissingFormLabel
- 2
Kaandorp S P, Goddijn M, van der Post J A et al..
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
N Engl J Med.
2010;
362
(17)
1586-1596
MissingFormLabel
- 3
van den Boogaard E, Kaandorp S P, Franssen M T et al..
Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier
status?.
Hum Reprod.
2010;
25
(6)
1411-1414
MissingFormLabel
- 4
Regan L, Rai R.
Epidemiology and the medical causes of miscarriage.
Best Pract Res Clin Obstet Gynaecol.
2000;
14
(5)
839-854
MissingFormLabel
- 5
Poland B J, Miller J R, Jones D C, Trimble B K.
Reproductive counseling in patients who have had a spontaneous abortion.
Am J Obstet Gynecol.
1977;
127
(7)
685-691
MissingFormLabel
- 6
Sierra S, Stephenson M.
Genetics of recurrent pregnancy loss.
Semin Reprod Med.
2006;
24
(1)
17-24
MissingFormLabel
- 7
Rai R, Regan L.
Recurrent miscarriage.
Lancet.
2006;
368
(9535)
601-611
MissingFormLabel
- 8
Rey E, Kahn S R, David M, Shrier I.
Thrombophilic disorders and fetal loss: a meta-analysis.
Lancet.
2003;
361
(9361)
901-908
MissingFormLabel
- 9
Robertson L, Wu O, Langhorne P Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study et al.
Thrombophilia in pregnancy: a systematic review.
Br J Haematol.
2006;
132
(2)
171-196
MissingFormLabel
- 10
Morrison E R, Miedzybrodzka Z H, Campbell D M et al..
Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension:
results from a large population-based study and systematic review.
Thromb Haemost.
2002;
87
(5)
779-785
MissingFormLabel
- 11
Ridker P M, Miletich J P, Hennekens C H, Buring J E.
Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous
thromboembolism screening.
JAMA.
1997;
277
(16)
1305-1307
MissingFormLabel
- 12
Poort S R, Rosendaal F R, Reitsma P H, Bertina R M.
A common genetic variation in the 3′-untranslated region of the prothrombin gene is
associated with elevated plasma prothrombin levels and an increase in venous thrombosis.
Blood.
1996;
88
(10)
3698-3703
MissingFormLabel
- 13
Lockwood C J.
Inherited thrombophilias in pregnant patients.
Prenat Neonatal Med.
2001;
6
3-14
MissingFormLabel
- 14
Bank I, van de Poel M H, Coppens M et al..
Absolute annual incidences of first events of venous thromboembolism and arterial
vascular events in individuals with elevated FVIII:c. A prospective family cohort
study.
Thromb Haemost.
2007;
98
(5)
1040-1044
MissingFormLabel
- 15
Kamphuisen P W, Lensen R, Houwing-Duistermaat J J et al..
Heritability of elevated factor VIII antigen levels in factor V Leiden families with
thrombophilia.
Br J Haematol.
2000;
109
(3)
519-522
MissingFormLabel
- 16
Rosendaal F R, Koster T, Vandenbroucke J P, Reitsma P H.
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein
C resistance).
Blood.
1995;
85
(6)
1504-1508
MissingFormLabel
- 17
Coppens M, Kaandorp S P, Middeldorp S.
Inherited thrombophilias.
Obstet Gynecol Clin North Am.
2006;
33
(3)
357-374
MissingFormLabel
- 18
Middeldorp S, van Hylckama Vlieg A.
Does thrombophilia testing help in the clinical management of patients?.
Br J Haematol.
2008;
143
(3)
321-335
MissingFormLabel
- 19
Cohn D M, Roshani S, Middeldorp S.
Thrombophilia and venous thromboembolism: implications for testing.
Semin Thromb Hemost.
2007;
33
(6)
573-581
MissingFormLabel
- 20
Hellgren M.
Hemostasis during normal pregnancy and puerperium.
Semin Thromb Hemost.
2003;
29
(2)
125-130
MissingFormLabel
- 21
Kujovich J L.
Thrombophilia and pregnancy complications.
Am J Obstet Gynecol.
2004;
191
(2)
412-424
MissingFormLabel
- 22
Salmon J E, Girardi G, Lockshin M D.
The antiphospholipid syndrome as a disorder initiated by inflammation: implications
for the therapy of pregnant patients.
Nat Clin Pract Rheumatol.
2007;
3
(3)
140-147; quiz 1, 187
MissingFormLabel
- 23
Quenby S, Mountfield S, Cartwright J E, Whitley G S, Chamley L, Vince G.
Antiphospholipid antibodies prevent extravillous trophoblast differentiation.
Fertil Steril.
2005;
83
(3)
691-698
MissingFormLabel
- 24
Bose P, Black S, Kadyrov M et al..
Heparin and aspirin attenuate placental apoptosis in vitro: implications for early
pregnancy failure.
Am J Obstet Gynecol.
2005;
192
(1)
23-30
MissingFormLabel
- 25
Isermann B, Sood R, Pawlinski R et al..
The thrombomodulin-protein C system is essential for the maintenance of pregnancy.
Nat Med.
2003;
9
(3)
331-337
MissingFormLabel
- 26
Ivanov P D, Komsa-Penkova R S, Konova E I, Kovacheva K S, Simeonova M N, Popov J D.
Association of inherited thrombophilia with embryonic and postembryonic recurrent
pregnancy loss.
Blood Coagul Fibrinolysis.
2009;
20
(2)
134-140
MissingFormLabel
- 27
Alfirevic Z, Roberts D, Martlew V.
How strong is the association between maternal thrombophilia and adverse pregnancy
outcome? A systematic review.
Eur J Obstet Gynecol Reprod Biol.
2002;
101
(1)
6-14
MissingFormLabel
- 28
Hirsh J, Warkentin T E, Shaughnessy S G et al..
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics,
dosing, monitoring, efficacy, and safety.
Chest.
2001;
119
(1, Suppl)
64S-94S
MissingFormLabel
- 29
Badawy A M, Khiary M, Sherif L S, Hassan M, Ragab A, Abdelall I.
Low-molecular weight heparin in patients with recurrent early miscarriages of unknown
aetiology.
J Obstet Gynaecol.
2008;
28
(3)
280-284
MissingFormLabel
- 30
Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey A A, Mosbah A.
Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage:
a randomized placebo-controlled study.
Arch Gynecol Obstet.
2008;
278
(1)
33-38
MissingFormLabel
- 31
Clark P, Walker I D, Langhorne P Scottish Pregnancy Intervention Study (SPIN) collaborators et al.
SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled
trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent
miscarriage.
Blood.
2010;
115
(21)
4162-4167
MissingFormLabel
- 32
Laskin C A, Spitzer K A, Clark C A et al..
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from
the randomized, controlled HepASA Trial.
J Rheumatol.
2009;
36
(2)
279-287
MissingFormLabel
- 33
Visser J, Ulander V M, Helmerhorst F M et al..
Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia.
HABENOX: a randomised multicentre trial.
Thromb Haemost.
2011;
105
(2)
295-301
MissingFormLabel
- 34
Greer I A, Nelson-Piercy C.
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism
in pregnancy: a systematic review of safety and efficacy.
Blood.
2005;
106
(2)
401-407
MissingFormLabel
- 35
Byrd L, Shiach C, Johnston T, Hay C.
Osteopenic fractures in pregnancy: is low molecular weight heparin (LMWH) implicated?.
J Obstet Gynaecol.
2008;
28
(5)
539-542
MissingFormLabel
- 36
Bank I, Libourel E J, Middeldorp S, Van Der Meer J, Büller H R.
High rate of skin complications due to low-molecular-weight heparins in pregnant women.
J Thromb Haemost.
2003;
1
(4)
859-861
MissingFormLabel
- 37
Machin S J.
Pros and cons of thrombophilia testing: cons.
J Thromb Haemost.
2003;
1
(3)
412-413
MissingFormLabel
- 38
Cohn D M, Vansenne F, Kaptein A A, De Borgie C A, Middeldorp S.
The psychological impact of testing for thrombophilia: a systematic review.
J Thromb Haemost.
2008;
6
(7)
1099-1104
MissingFormLabel
- 39
Hellmann E A, Leslie N D, Moll S.
Knowledge and educational needs of individuals with the factor V Leiden mutation.
J Thromb Haemost.
2003;
1
(11)
2335-2339
MissingFormLabel
- 40
Lindqvist P G, Dahlbäck B.
Reactions to awareness of activated protein C resistance carriership: a descriptive
study of 270 women.
Acta Obstet Gynecol Scand.
2003;
82
(5)
467-470
MissingFormLabel
- 41
Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H.
A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent
miscarriages.
Fertil Steril.
2006;
86
(2)
362-366
MissingFormLabel
Paulien de JongM.D.
Academic Medical Center
Amsterdam, Netherlands
eMail: p.g.dejong@amc.uva.nl